These recalls involve products that pose serious risks of injury or death. Check if you own any of these products and take immediate action if needed.

High Risk Recalls

3,615 critical product recalls that require immediate attention. These products have been identified as posing serious safety hazards.

What to do if you own a recalled product:

  1. Stop using the product immediately
  2. Keep the product away from children
  3. Follow the remedy instructions provided
  4. Contact the manufacturer for a refund or replacement
Health & Personal Care
HIGH
FDA DEVICE

Raz Design Raz-AT Mobile Shower Commode Chair Recall for 66 Units Over Bracket Engagement Hazard (Z-

Raz Design Inc recalled 66 Raz Mobile Shower Commode Chairs nationwide, citing a modification that may allow the seat to detach if outside rear brackets are not properly engaged. The recall covers multiple catalog numbers and serial ranges. Patients and healthcare providers should stop using the device immediately and contact Raz Design for instructions.

Raz Design
Due to
Read more
Health & Personal Care
HIGH
FDA DEVICE

Encore Medical Recalls EMPOWR Acetabular System Over Packaging Errors

Encore Medical, LP recalled 49 units of the EMPOWR Acetabular System on January 5, 2026. Packaging errors may cause surgical delays, potentially affecting patient safety. Healthcare providers should stop using these devices immediately.

Encore Medical, LP
942-01-40G acetabular
Read more
Health & Personal Care
HIGH
FDA DEVICE

Encore Medical Recalls Knee Tibial Insert Due to Packaging Error

Encore Medical, LP recalled 19 units of the EMPOWR 3D Knee Tibial Insert on January 5, 2026. The recall follows the discovery of a packaging error that may cause surgical delays. Healthcare providers and patients should stop using the device immediately.

Encore Medical, LP
942-01-40G acetabular
Read more
Health & Personal Care
HIGH
FDA DEVICE

Alphatec Spine Recalls Surgical Instruments Over Connection Issue

Alphatec Spine recalled 7 units of Lateral Navigation Disc Prep Instruments on January 2, 2026, due to a design flaw. The incorrect navigated array connection geometry poses a high hazard risk in surgical settings. Healthcare providers and patients must stop using the devices immediately.

Alphatec Spine
Due a
Read more
Vehicles & Parts
HIGH
NHTSA

Toyota Sienna Hybrid Recall 2025 Over Third-Row Seatback Bolts

Toyota recalls 2021-2025 Sienna Hybrid vehicles for third-row seatback bolts that may not be tightened. The unsecured bolts may fail to restrain occupants in a crash. Owners should contact their Toyota dealer for inspection and service; recall number 25TA05; letters were mailed April 1, 2025.

Toyota
An improperly
Read more
Health & Personal Care
HIGH
FDA DRUG

Cipla Lanreotide Acetate Injection Recall: 15,221 Syringes Over Particulate Matter (2026)

Cipla USA, Inc. is recalling 15,221 Lanreotide Acetate Injection syringes nationwide in the United States after detecting particulate matter. The defect is the presence of particulate matter in the injectable solution. Healthcare providers and patients should stop using the product immediately and contact Cipla USA for guidance.

LANREOTIDE ACETATE
Presence of
Read more
Health & Personal Care
HIGH
FDA DEVICE

AVID Medical Recalls Transport Bag Kit Over Sterility Risk

AVID Medical recalled 1,500 units of the TRANSPORT BAG KIT on January 2, 2026. A seal issue with the Tyvek bag may compromise the sterility of the kit. The recall affects healthcare providers and patients in New Jersey.

AVID Medical
Tyvek bag
Read more
Vehicles & Parts
HIGH
NHTSA

Kia Recalled 2025 Sorento Hybrid and 2024-2025 Sorento SUVs for BDC Software Issue

Kia America recalled 2025 Sorento Hybrid and 2024-2025 Sorento SUVs sold at Kia dealerships nationwide after a body domain control software fault may disable low beam headlights and taillights. The defect can reduce visibility and raise crash risk. Owners should contact a Kia dealer for a free software update under recall SC331; notifications were mailed Feb. 21, 2025.

Kia
A loss
Read more
Health & Personal Care
HIGH
FDA DRUG

Alvogen Recalls Levothyroxine Sodium Tablets Due to Mix-Up

Alvogen, Inc. recalled Levothyroxine Sodium Tablets on January 21, 2026, after a pharmacy reported a mix-up with dosages. Some bottles contained 88 mcg tablets instead of the prescribed 150 mcg. The recall affects 1,000 tablets from lot # MHA21825, with an expiration date of December 31, 2027.

LEVOTHYROXINE SODIUM
Product Mix-Up:
Read more
Health & Personal Care
HIGH
FDA DRUG

Wizcure Pharmaa Recalls Vista Gel Eye Drops Due to Sterility Issues

Wizcure Pharmaa recalled 17,280 cartons of Vista Gel Hypromellose eye drops on December 31, 2025. The recall stems from a lack of assurance of sterility, raising potential health risks for users. Consumers should stop using the product immediately and contact their healthcare provider for guidance.

VISTA HYPROMELLOSE DRY EYE RELIEF
Lack of
Read more
Food & Beverages
HIGH
FDA FOOD

WFM Purchasing Recalls Brussel Sprouts & Kale Slaw Over Allergen Risk

WFM Purchasing, LP recalled 88 units of Brussel Sprouts & Kale Slaw on December 31, 2025. The product contains undeclared fish and egg allergens, posing a serious health risk. Consumers in New York, New Jersey, and Virginia should not consume this product.

WFM Purchasing, LP
Undeclared Fish
Read more
Health & Personal Care
HIGH
FDA DRUG

Wizcure Pharmaa Recalls Fluorescein Sodium Ophthalmic Strips Over Sterility Concerns

Wizcure Pharmaa recalled 10,080 boxes of Fluorescein Sodium Ophthalmic Strips on December 31, 2025, due to sterility issues. The recall affects products packaged in 100-count and 300-count boxes. Consumers should stop using these products immediately and consult healthcare providers for guidance.

C20H10NA2O5 FLUORESCEIN SODIUM OPHTHALMIC STRIPS
Lack of
Read more
Health & Personal Care
HIGH
FDA DRUG

Wizcure Pharmaa Recalls Eye Drops Due to Sterility Risk

Wizcure Pharmaa PVT. LTD. recalled 11,520 cartons of Vista Meibo Tears Eye Drops on December 31, 2025. The recall occurred due to lack of assurance of sterility, posing a high risk to consumers. The affected product was distributed nationwide in the USA.

VISTA MEIBO TEARS PROPYLENE GLYCOL 0.6% W/V ADVANCED DRY EYE RELIEF LUBRICATING DROPS 10 ML
Lack of
Read more
Health & Personal Care
HIGH
FDA DRUG

BioGlo Ophthalmic Strips Recalled Over Sterility Concerns

BioGlo Fluorescein Sodium Ophthalmic Strips are recalled due to sterility issues. The recall affects 184,320 containers distributed nationwide in the USA. Consumers should stop using the product immediately.

Wizcure Pharmaa Private
Lack of
Read more
Health & Personal Care
HIGH
FDA DRUG

Wizcure Pharmaa Recalls Eye Drops Due to Sterility Concerns

Wizcure Pharmaa recalled 5,760 cartons of Vista Tears Eye Drops on December 31, 2025. The recall follows a lack of assurance of sterility in the product. Consumers should stop using the drops immediately and contact a healthcare provider for guidance.

Wizcure Pharmaa Private
Lack of
Read more
Health & Personal Care
HIGH
FDA DRUG

Wizcure Pharmaa Recalls Ophthalmic Strips Over Sterility Concerns

Wizcure Pharmaa recalled 50,400 boxes of Bio Glo Fluorescein Sodium Ophthalmic Strips on December 31, 2025. The recall follows concerns regarding lack of assurance of sterility, as products did not conform to good manufacturing practices. Consumers should stop using the product immediately and consult healthcare providers.

Wizcure Pharmaa Private
Lack of
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medline Industries Recalls IV Administration Sets Due to Leakage Risk

Medline Industries recalled over 926,000 IV Administration and Extension Sets due to a significant risk of leaks and breaks. The recall affects multiple models with potential exposure to chemicals and mechanical forces. Users should discontinue use immediately to prevent serious health risks including blood loss and infections.

Medline Industries, LP
Under circumstances
Read more
Health & Personal Care
HIGH
FDA DEVICE

Medica Recalls Capillary Tube Kit Over False Potassium Readings

Medica recalled 1,578 units of its Capillary Tubes on December 31, 2025. A systematic positive bias of up to 20% can produce false elevation results in patient potassium levels. Healthcare providers and patients must stop using the device immediately.

Medica
A systematic
Read more
Advertisement